The Program Management team in the Clinical Development Office at Moderna is responsible for management of the clinical-stage programs from IND to licensure. Moderna is seeking a motivated and energetic Program Manager to help drive their program teams forward in the development of novel mRNA medicines within the Moderna Therapeutics Area. The Therapeutics Area at Moderna is currently exploring mRNA medicines in Auto-Immune, Cardiovascular, Pulmonary disorders as well as in Rare Diseases. The successful candidate will work in close coordination with the Program Leader and the cross-functional Program Team to enable execution of the program strategy. Each program manager may be assigned 1-3 programs or sub-program within a Franchise depending on the phase of development. The successful program manager will have program management experience across multiple phases of development (pre-clinical and/or clinical) preferably in one or more of the focus areas for Moderna Therapeutics.
Here’s What You’ll Do:
The Program manager will be involved in high-level supervision of the programs by:
Partnering with the program leader to shape program strategy and execution plan.
Collaborating with functional leads to define program strategy and proactively identify and escalate gaps and challenges; Managing team through scenario planning to solve problems.
Building relationships with key stakeholders (team members and leadership) to ensure alignment of functional and corporate objectives; Leveraging organizational dynamics to promote program goals.
Coordinating team efforts to develop impactful presentations to summarize complex topics into critical points to facilitate strategic planning and decision-making, Preparing program status update and governance presentations to the Development Review Committee (DRC) and Executive Committee.
Developing and tracking activities against program timelines and budget.
Administering the day-to-day activities, including, facilitating cross-functional team meeting, leading discussions to drive decision-making, preparing agenda and meeting minutes, defining and resolving actions items.
Working with the Finance group to implement and track program budget.
Contributing to Program Management initiatives to support development and scaling of capabilities, tools and processes.
Here’s What You’ll Bring to the Table:
BS degree in a scientific field with 10 years of experience or MS degree in a scientific field with 6-8 years of experience in a biotechnology or pharmaceutical setting
Experience in drug development (preferably in one or more focus area for Moderna Therapeutics) across multiple phases (pre-clinical and/or clinical Phase 1-3).
Proven track record of successful project management experience supporting late-stage programs
Prior experience managing or working within cross-functional project teams with timeline management and budgetary responsibility
Strong knowledge of project management tools and software
Must be adept at working in a fluid environment and foster a strong collaborative spirit internally and externally.
Strong personal skills to influence without authority, motivate others and manage conflict.
Strong written and oral communication skills as well as demonstrated organizational aptitude
Strong working knowledge of MS Project, Smartsheet, and timeline visualization software
Preferred: PhD or PharmD and 2+ years of experience in a biotechnology or pharmaceutical setting
Preferred: Laboratory experience in an academic or biotechnology setting
Preferred: Project/program management training
Preferred: Experience with vaccine development.
Moderna is pleased to provide you and your family with a comprehensive and innovative suite of benefits, including:
Candidates should be aware that Moderna currently maintains a policy requiring all US-based employees to be fully vaccinated against COVID-19 and receive a booster shot once eligible. Newly hired employees must be vaccinated and boosted prior to their employment start date. Moderna is an equal opportunity employer and will provide a reasonable accommodation to those unable to be vaccinated or receive a booster where it is not an undue hardship to the company to do so as provided under federal, state, and local law.
In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic.
Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit www.modernatx.com.
Moderna is a smoke-free, alcohol-free and drug-free work environment.
Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.#LI-MS1